STAT60%
Michigan Supreme Court ruling allows probe into Lilly insulin pricing 45%
By Ed Silverman75%
8/2/2026, 11:14:14 AM
BS Summary: This article contains 9 faulty reasoning types, including Appeal to Emotion, Ambiguity (Equivocation), and Confirmation Bias, with Negativity Bias as the most egregious example at 40.3% saturation with 56 hits. Analysis detected 279 faulty-reasoning hits from 139 analyzed words, generating a BS Score of 41.4% and a BS Rank of 45% (15,058 of 27,320 articles). This article is better (less manipulative) than 55.10% of the article peer group.
A divided Michigan Supreme Court ruled on Friday that the state’s attorney general may investigate Eli Lilly over its pricing practices for insulin.
In its 4-to-3 decision, the court rejected a lower court decision that prevented Michigan Attorney General Dana Nesel from proceeding with a probe that began four years ago.
At the time, Nessel cited state consumer protection laws, alleging the drug maker had artificially increased the price of its insulin medication.
Lilly was accused of charging “grossly” excessive prices for three different insulin products — Lispro, Humalog and Basaglar — that forced some patients to ration or forego insulin, restrict their diets or buy less-effective alternatives.
These practices led to “serious disability and even death in some patients,” the state wrote in court documents at the time.
Speakers
1speaker16%attributed speech117writer words
Selected voice
100%flagged-word coverageDana Nesel
22 attributed words100% of attributed speech100% writer coverage
Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.
Loading…
Loading…
Loading…
Loading…
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.